Evidence map›Paper›PMID 40821738›Full record

ArticleTherapeutic advances in gastroenterology2025

Prospective validation of the Barcelona scale for the assessment of mucosal cleanliness during upper gastrointestinal endoscopy.

Henry Córdova, Irina Luzko, Javier Tejedor-Tejada, Edgar Castillo-Regalado, Eva Barreiro-Alonso, Pedro Delgado-Guillena, Pilar Diez Redondo, Martin Galdin, Ana García-Rodríguez, Luis Hernández and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Henry CórdovaEndoscopy Unit, Gastroenterology Department, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
Irina LuzkoEndoscopy Unit, Gastroenterology Department, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
Javier Tejedor-TejadaDepartment of Gastroenterology, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.
Edgar Castillo-RegaladoEndoscopy Unit, Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Eva Barreiro-AlonsoDepartment of Gastroenterology, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Pedro Delgado-GuillenaHospital de Mérida, Mérida, Badajoz, Spain.
Pilar Diez RedondoHospital Universitario Río Hortega, Valladolid, Spain.
Martin GaldinConsorci Hospitalari de Vic, Vic, Spain.
Ana García-RodríguezServicio de Digestivo, Unidad de Endoscopia, Hospital de Viladecans, Barcelona, Spain.
Luis HernándezHospital Santos Reyes, Aranda de Duero, Spain.
Ma Henar Núñez RodríguezHospital Universitario Río Hortega, Valladolid, Spain.
Agustín SeoaneDigestive Department, Endoscopy Unit, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.
Javier Jiménez SánchezHospital de Orihuela, Alicante, Spain.
Joaquín CubiellaDepartment of Gastroenterology, Hospital Universitario de Ourense, Research Group in Gastrointestinal Oncology-Ourense, CIBERehd, Ourense, Spain.
Rodrigo JoverServicio de Medicina Digestiva, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria ISABIAL, Universidad Miguel Hernández, Alicante, Spain.
Antonio Rodríguez-D'JesúsHospital Álvaro Cunqueiro, Vigo, Spain.
Cautar El MaimouniEndoscopy Unit, Gastroenterology Department, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
Leticia MoreiraEndoscopy Unit, Gastroenterology Department, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
Oswaldo OrtizEndoscopy Unit, Gastroenterology Department, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
Joan LlachEndoscopy Unit, Gastroenterology Department, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
Gloria Fernández-EsparrachEndoscopy Unit, Gastroenterology Department, Hospital Clínic, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, Barcelona 08036, Spain.ORCID https://orcid.org/0000-0002-3378-3940

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Some validated scales for assessing upper gastrointestinal (UGI) cleanliness have been developed, though none have been widely implemented. Objectives: To evaluate the association between the presence of clinically significant lesions (CSLs) in the UGI tract and mucosal cleanliness using the Barcelona Scale. The secondary objective includes assessing the safety of water lavage during esophagogastroduodenoscopy (EGD). Design: Multicenter prospective study conducted in 14 hospitals in Spain. Methods: From January 2022 to December 2023, patients undergoing EGD were included. After cleansing, the esophagus, fundus, corpus, antrum, and duodenum were scored from 0 (unassessable due to content) to 2 (fully visualized mucosa), with a maximum score of 10. Results: A total of 641 patients were included, and 3205 segments were assessed: 2594 scored "2," 604 "1," and 7 "0." In 272 patients, 327 CSLs were identified: 93 (14.5%) in the esophagus, 223 (34.8%) in the stomach, and 11 (1.7%) in the duodenum. Only five cases of neoplasia were found, all in segments scored "2" (global score ⩾ 9). The CSL detection rates were 0%, 5.3%, and 11.4% for scores 0, 1, and 2, respectively ( Conclusion: The Barcelona scale may be a valid instrument for assessing the quality of cleanliness during EGD in real clinical practice, as it improves the detection of CSL in the UGI.

Indexed as

cleanlinessesophagogastroduodenoscopyqualityupper gastrointestinal tractvisualization

Identifiers

PMID40821738
PMCPMC12357016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.